Mindfulness and CBT for Preventing Severe Mental Illness in Youth
(SWELL Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment maCBT, Mindfulness and Acceptance-based Cognitive Behavioral Therapy, for preventing severe mental illness in youth?
Research shows that mindfulness-based interventions can help reduce psychological symptoms and improve emotion regulation in young people. Studies have found that these interventions lead to small but positive effects on mental health, with some evidence suggesting that acceptance skills are crucial for their success.12345
Is Mindfulness and Acceptance-based Cognitive Behavioral Therapy safe for young people?
Research on mindfulness-based therapies, including Mindfulness-Based Cognitive Therapy (MBCT) and Acceptance and Commitment Therapy (ACT), suggests they are generally safe for children and adolescents. These therapies have been used in various settings and have shown promise in improving mental health without significant safety concerns.678910
How is the treatment maCBT different from other treatments for preventing severe mental illness in youth?
maCBT is unique because it combines mindfulness (being present and aware without judgment) with cognitive behavioral therapy (CBT), focusing on acceptance and emotion regulation to prevent severe mental illness in youth. This approach is different from traditional treatments as it emphasizes mindfulness and acceptance as key components to improve mental health outcomes.156910
What is the purpose of this trial?
Severe mental illness such as schizophrenia and mood disorders typically develops at a young age and can cause life-long disability. Currently available treatments cannot cure severe mental illness. This makes it important to find ways to prevent severe mental illness in young people before it has a chance to develop. This research study will pilot a new preventive intervention for young people who are at high risk of developing severe mental illness. The investigators will target early preceding factors (the 'antecedents') to severe mental illness which includes anxiety, unusual hearing and visual experiences, the loss of previously acquired abilities, and sudden and unpredictable changes in mood. These antecedents strongly predict an increased risk of developing severe mental illness. They are often impairing and distressing to the individual but can be improved with self-management skills and parent training, and they are present in the individual years before the onset of severe mental illness which makes them an ideal target for early intervention. The goal is to intervene early enough in the young person's life that severe mental illness can be prevented, hopefully leading to a happy, healthy and productive adulthood. The investigators want to test the acceptability and short-term efficacy of this new preventive intervention.
Research Team
Rudolf Uher, MD
Principal Investigator
Nova Scotia Health Authority
Eligibility Criteria
This trial is for young individuals aged 9-21 who are part of the FORBOW study, showing early signs that may predict severe mental illness, like anxiety or mood swings. It's not for those with a severe mental illness diagnosis or who've had significant therapy recently.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Multimodal Antecedent-focussed Cognitive-behavioural Training (maCBT) in 8 to 16 one-hour sessions, initially weekly, then bi-weekly.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 4-6 months, 1, 2, 3, and 5 years post intervention.
Long-term follow-up
Annual follow-ups to assess long-term outcomes such as severe mental illness diagnosis and functioning.
Treatment Details
Interventions
- maCBT
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nova Scotia Health Authority
Lead Sponsor
Nova Scotia Health Research Foundation
Collaborator
Canadian Institutes of Health Research (CIHR)
Collaborator